2016 ASHP Pediatric Pharmacy Specialty Review and Recertification Course
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
2016 ASHP Pediatric Pharmacy Specialty
Review and Recertification Course
AGENDA
SATURDAY, JUNE 11TH
7:30 a.m. – 8:05 a.m. Welcome/Introductions and Tips for Success
Jamie Miller, Pharm.D., BCPS, BCPPS
8:05 a.m. – 9:35 a.m. Complex Case: Neonatal Sepsis
Jamie Miller, Pharm.D., BCPS, BCPPS
ACPE Number: 0204-0000-16-941-L01-P
Application-based: 1.5 credit hours
Objectives:
At the end of the presentation, the pharmacist should be able to:
1. Correctly answer case-based questions about appropriate treatment and
monitoring of a complex neonatal patient with multiple conditions,
including patent ductus arteriosus, apnea of prematurity, early and late
onset sepsis, and necrotizing enterocolitis.
2. Evaluate the clinical and therapeutic implications of placental transfer of
medications.
3. Identify age-specific pharmacokinetic differences among neonates, infants,
children, and adolescents.
4. Incorporate FDA Alerts for adverse drug events and drug-drug interactions
into clinical practice.
9:35 a.m. – 9:50 a.m. Break
9:50 a.m. – 11:20 a.m. Complex Case: Acute Lymphoblastic Leukemia and Supportive Care
Jennifer Thackray, Pharm.D., BCPS, BCPPS
ACPE Number: 0204-0000-16-942-L01-P
Application-based: 1.5 credit hours
Objectives:
At the end of the presentation, the pharmacist should be able to:
1. Correctly answer case-based questions about appropriate treatment and
monitoring of a complex pediatric patient with multiple conditions,
including acute lymphoblastic leukemia (ALL), tumor lysis syndrome, febrile
neutropenia, invasive aspergillosis infection, and Clostridium difficile
infection.
2. Select appropriate medication dose modifications related to hepatic
impairment.
Page 1 of 82016 ASHP Pediatric Pharmacy Specialty
Review and Recertification Course
SATURDAY, JUNE 11TH (CONT.)
11:20 a.m. – 11:50 a.m. Regulatory and IRB Considerations
Peter N. Johnson, Pharm.D., BCPS, BCPPS
ACPE Number: 0204-0000-16-943-L03-P
Knowledge-based: 0.5 credit hours
Objectives:
At the end of the presentation, the pharmacist should be able to:
1. Identify appropriate off-label use of medications in the pediatric
population.
2. Recognize Institutional Review Board (IRB) requirements for
documentation of clinical studies.
3. List characteristics of patients who require informed assent/consent.
4. Recognize federal legislation relevant to the use of medications in pediatric
patients.
11:50 a.m. – 1:05 p.m. Lunch
1:05 p.m. – 2:35 p.m. Complex Case: Deep Vein Thrombosis and Metabolic Syndrome
Kelly L. Matson, B.S.Nutr., Pharm.D., BCPPS
ACPE Number: 0204-0000-16-944-L01-P
Application-based: 1.5 credit hours
Objectives:
At the end of the presentation, the pharmacist should be able to:
1. Correctly answer case-based questions about appropriate treatment and
monitoring of a complex pediatric patient with multiple conditions,
including deep vein thrombosis, type 2 diabetes mellitus, dyslipidemia, and
hypertension.
2. Identify resources and treatment options for sexually transmitted
infections.
3. Select appropriate monitoring considerations of anticoagulation
medications.
4. Recognize the impact of pharmacogenomic differences on warfarin
therapy.
Page 2 of 82016 ASHP Pediatric Pharmacy Specialty
Review and Recertification Course
SATURDAY, JUNE 11TH (CONT.)
2:35 p.m. – 4:05 p.m. Complex Case: Diabetic Ketoacidosis
Rachel Meyers, Pharm.D., BCPS, BCPPS
ACPE Number: 0204-0000-16-945-L01-P
Application-based: 1.5 credit hours
Objectives:
At the end of the presentation, the pharmacist should be able to:
1. Correctly answer case-based questions about appropriate treatment and
monitoring of a complex pediatric patient with multiple conditions,
including diabetic ketoacidosis, type 1 diabetes mellitus, and urinary tract
infection.
2. Calculate maintenance and replacement fluid requirements and urine
output.
3. Identify factors affecting medication adherence.
4. Determine appropriate dosing of insulin based on patient age and weight.
5. Select an effective method of delivery for insulin.
4:05 p.m. – 4:20 p.m. Break
4:20 p.m. – 5:50 p.m. Complex Case: Acute Asthma
Jill A. Morgan, Pharm.D., BCPS, BCPPS
ACPE Number: 0204-0000-16-946-L01-P
Application-based: 1.5 credit hours
Objectives:
At the end of the presentation, the pharmacist should be able to:
1. Correctly answer case-based questions about appropriate treatment and
monitoring of a complex pediatric patient with multiple conditions,
including acute and chronic asthma, ADHD, acne and GERD.
2. Evaluate essential components of social history, including smoke exposure
and home environment.
3. Formulate a plan to address barriers to patient education and adherence,
including age, language, cultural considerations, and inhaler technique.
4. Describe the impact of age on classification and management of asthma.
5. Assess available resources to improve access to medications, including
patient assistance programs.
Page 3 of 82016 ASHP Pediatric Pharmacy Specialty
Review and Recertification Course
SUNDAY, JUNE 12TH
7:30 a.m. – 7:35 a.m. Announcements
7:35 a.m. – 8:35 a.m. Research Design, Evidence-Based Medicine and Statistical Analysis,
Part 1
Linda Tyler, Pharm.D., FASHP
ACPE Number: 0204-0000-16-947-L04-P
Application-based: 2 credit hours
Objectives:
At the end of the presentation, the pharmacist should be able to:
1. Interpret biomedical literature with regard to study design, methodology,
statistical analysis, and significance and applicability of reported data and
conclusions.
2. Summarize key points from the most current pharmacy practice literature.
3. Explain the use of evidence-based treatment guidelines and protocols.
8:35 a.m. – 8:50 a.m. Break
8:50 a.m. – 9:50 a.m. Research Design, Evidence-Based Medicine and Statistical Analysis,
Part 2
Linda Tyler, Pharm.D., FASHP
*See Part 1 Above
9:50 a.m. – 10:00 a.m. Break
10:00 a.m. – 10:15 a.m. Board of Pharmacy Specialties Examination Overview
Brian Lawson, Pharm.D.
10:15 a.m. – 11:45 a.m. Complex Case: Sickle Cell Disease with Vaso-Occlusive Crisis
Emily S. Waite, Pharm.D., BCOP
ACPE Number: 0204-0000-16-948-L01-P
Application-based: 1.5 credit hours
Objectives:
At the end of the presentation, the pharmacist should be able to:
1. Correctly answer case-based questions about appropriate treatment and
monitoring of a complex pediatric patient with multiple conditions,
including a vaso-occlusive crisis, cellulitis, constipation, and need for
immunizations.
2. Select most appropriate patient controlled analgesia regimen based on
vaso-occlusive crisis severity.
3. Identify required immunizations for adolescents, including patients with
risk factors for vaccine-preventable diseases.
4. Apply pharmacodynamic principles when selecting appropriate antibiotic
regimens.
Page 4 of 82016 ASHP Pediatric Pharmacy Specialty
Review and Recertification Course
Sunday, June 12th (Cont.)
11:45 a.m. – 1:00 p.m. Lunch
1:00 p.m. – 2:30 p.m. Complex Case: Medication Error & Practice Management
Lisa Thames, Pharm.D., BCPS
ACPE Number: 0204-0000-16-949-L05-P
Application-based: 1.5 credit hours
Objectives:
At the conclusion of this activity, the participant should be able to incorporate
position statements, white papers, national guidelines from recognized
regulatory organizations into institutional policies and procedures related to:
1. Medication reconciliation
2. Appropriate drug preparation and delivery (e.g., extemporaneous
compounding and standardized concentrations)
3. Selecting equipment/technology and decision support
4. Adverse drug event monitoring and reporting
5. Metrics for evaluating quality of pediatric pharmacy services.
2:30 p.m. – 4:00 p.m. Complex Case: Pneumonia and Septic Shock
Kaitlin Hughes, Pharm.D., BCPPS
ACPE Number: 0204-0000-16-950-L01-P
Application-based: 1.5 credit hours
Objectives:
At the end of the presentation, the pharmacist should be able to:
1. Correctly answer case-based questions about appropriate treatment and
monitoring of a complex pediatric patient with multiple conditions,
including pneumonia, septic shock, acute kidney injury, and parenteral
nutrition.
2. Calculate creatinine clearance, fluid requirements, and urine output in
pediatric patients.
3. Select appropriate dosing for medications based on renal dysfunction
and/or replacement modalities.
4. Differentiate vital signs between stable and critically ill pediatric patients.
4:00 p.m. – 4:15 p.m. Break
Page 5 of 82016 ASHP Pediatric Pharmacy Specialty
Review and Recertification Course
Sunday, June 12th (Cont.)
4:15 p.m. – 5:45 p.m. Complex Case: Status Epilepticus and Cardiopulmonary Resuscitation
Peter N. Johnson, Pharm.D., BCPS, BCPPS
ACPE Number: 0204-0000-16-951-L01-P
Application-based: 1.5 credit hours
Objectives:
At the end of the presentation, the pharmacist should be able to:
1. Correctly answer case-based questions about appropriate treatment and
monitoring of a complex pediatric patient with multiple conditions and
needs, including status epilepticus, cardiopulmonary resuscitation, and
sedation/analgesia.
2. Differentiate treatment options in cardiopulmonary arrest based on
patient presentation.
3. Select the appropriate dose and route of administration for medications.
4. Assess the need and processes for reporting adverse drug events.
5. Identify cultural considerations related to treatment and counseling of the
pediatric population.
6. Distinguish between the four preceptor roles.
5:45 p.m. – 6:00 p.m. Closing Remarks
Page 6 of 82016 ASHP Pediatric Pharmacy Specialty
Review and Recertification Course
ACCREDITATION FOR PHARMACISTS
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for
Pharmacy Education as a provider of continuing pharmacy education.
FACULTY
Kaitlin Hughes, Pharm.D., BCPPS
Clinical Pharmacy Specialist Pediatric Surgery
Adjunct Clinical Instructor
C.S. Mott Children’s Hospital
Ann Arbor, Michigan
Peter N. Johnson, Pharm.D., BCPS, BCPPS*
Associate Professor of Pharmacy Practice
University of Oklahoma College of Pharmacy
Clinical Pharmacy Specialist – Pediatric Critical Care
The Children's Hospital at OU Medical Center
Oklahoma City, Oklahoma
Kelly L. Matson, B.S.Nutr., Pharm.D., BCPPS
Clinical Associate Professor
University of Rhode Island
Kingston, Rhode Island
Rachel Meyers, Pharm.D., BCPS, BCPPS
Clinical Associate Professor
Ernest Mario School of Pharmacy, Rutgers University
Piscataway, New Jersey
Pediatric Clinical Pharmacist
Saint Barnabas Medical Center
Livingston, New Jersey
Jamie Miller, Pharm.D., BCPS, BCPPS*
Associate Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma
Jill A. Morgan, Pharm.D., BCPS, BCPPS
Associate Professor and Chair
Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
Baltimore, Maryland
Page 7 of 82016 ASHP Pediatric Pharmacy Specialty
Review and Recertification Course
Faculty (Cont.)
Jennifer Thackray, Pharm.D., BCPS, BCPPS*
Pediatric Oncology Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, New York
Lisa Thames, Pharm.D., BCPS
Assistant Director, Clinical Pharmacy Services
UF Health Shands Hospital
Gainesville, Florida
Linda Tyler, Pharm.D., FASHP
Chief Pharmacy Officer
University of Utah Hospitals & Clinics
Salt Lake City, Utah
Emily S. Waite, Pharm.D., BCOP
Pediatric Hematology/Oncology Pharmacist
Children's of Alabama
Birmingham, Alabama
*Content matter experts
Page 8 of 8You can also read
